Range
1.1 - 1.16
Vol / Avg.
813.9K/3.8M
Div / Yield
-
52 Wk
0.36 - 4.23
Mkt Cap
55.8M
Payout Ratio
-
Open
1.14
P/E
-
EPS
-0.53
Shares
49.4M
Outstanding
49.4M
Total Float
49.3M
Benzinga - 4 days ago
Benzinga - Jun 3, 2021, 7:12AM
Benzinga - May 26, 2021, 9:17AM
Benzinga - May 26, 2021, 7:41AM
Benzinga - May 26, 2021, 6:53AM
Benzinga - May 25, 2021, 5:01PM
Benzinga - May 6, 2021, 4:03PM
Benzinga - Apr 15, 2021, 12:13PM
Benzinga - Mar 16, 2021, 8:01AM
Benzinga - Mar 12, 2021, 7:49AM
Benzinga - Mar 11, 2021, 4:28PM
load more
Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. Nabriva is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company is developing product candidate, lefamulin, to be the first pleuromutilin antibiotic available for systemic administration in humans. It operates in one reportable segment, which comprises the research and development of novel anti-infective agents to treat serious infections.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
NBRVNabriva Therapeutics-0.88%55.8M

Nabriva Therapeutics Frequently Asked Questions

Q

How do I buy Nabriva Therapeutics (NBRV) stock?

A

You can purchase shares of Nabriva Therapeutics (NASDAQ: NBRV) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Nabriva Therapeutics's (NBRV) competitors?

A

There are no as such competitors for Nabriva Therapeutics.

Q

What is the target price for Nabriva Therapeutics (NBRV) stock?

A

The latest price target for Nabriva Therapeutics (NASDAQ: NBRV) was reported by Morgan Stanley on December 7, 2020. The analyst firm set a price target for 20.00 expecting NBRV to rise to within 12 months (a possible 1669.91% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Nabriva Therapeutics (NBRV)?

A

The stock price for Nabriva Therapeutics (NASDAQ: NBRV) is $1.13 last updated Fri Jul 23 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Nabriva Therapeutics (NBRV) pay a dividend?

A

There are no upcoming dividends for Nabriva Therapeutics.

Q

When is Nabriva Therapeutics (NASDAQ:NBRV) reporting earnings?

A

Nabriva Therapeutics does not have any upcoming earnings scheduled.

Q

Is Nabriva Therapeutics (NBRV) going to split?

A

There is no upcoming split for Nabriva Therapeutics.

Q

What sector and industry does Nabriva Therapeutics (NBRV) operate in?

A

Nabriva Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.